Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

(2018) Zane Jaunmuktane et al.   ACTA NEUROPATHOLOGICA

Fatal Aβ cerebral amyloid angiopathy 4 decades after a dural graft at the age of 2 years

(2018) Dominique Hervé et al.   ACTA NEUROPATHOLOGICA

Minimally symptomatic cerebral amyloid angiopathy-related inflammation: three descriptive case reports

(2018) Gargi Banerjee et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Update: Dura Mater Graft–Associated Creutzfeldt-Jakob Disease — Japan, 1975–2017

(2018) Ryusuke Ae et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study

(2018) Ignazio Cali et al.   Acta Neuropathologica Communications

Autopsied case of non-plaque-type dura mater graft-associated Creutzfeldt-Jakob disease presenting with extensive amyloid-β deposition

(2018) Yasushi Iwasaki et al.   NEUROPATHOLOGY

Cerebral amyloid angiopathy associated with inflammation: A systematic review of clinical and imaging features and outcome

(2017) Andrej Corovic et al.   International Journal of Stroke

Cerebral amyloid angiopathy in a young man with a history of traumatic brain injury: a case report and review of the literature

(2016) Yoichi Nakayama et al.   ACTA NEUROCHIRURGICA

Dura mater is a potential source of Aβ seeds

(2016) Gabor G. Kovacs et al.   ACTA NEUROPATHOLOGICA

Significant association of cadaveric dura mater grafting with subpial Aβ deposition and meningeal amyloid angiopathy

(2016) Tsuyoshi Hamaguchi et al.   ACTA NEUROPATHOLOGICA

Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy–Related Inflammation

(2016) Carlo Salvarani et al.   MEDICINE

Mammalian prions and their wider relevance in neurodegenerative diseases

(2016) John Collinge   NATURE

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

(2016) Jeff Sevigny et al.   NATURE

Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years

(2015) Peter Rudge et al.   BRAIN

Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy

(2015) Zane Jaunmuktane et al.   NATURE

White Matter Changes in Dementia: Role of Impaired Drainage of Interstitial Fluid

(2014) Roy O. Weller et al.   BRAIN PATHOLOGY

Large APP locus duplication in a sporadic case of cerebral haemorrhage

(2014) Albert Lladó et al.   NEUROGENETICS

Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies

(2013) Fabrizio Piazza et al.   ANNALS OF NEUROLOGY

Validation of next-generation sequencing technologies in genetic diagnosis of dementia

(2013) John Beck et al.   NEUROBIOLOGY OF AGING

Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology

(2012) T. Muayqil et al.   NEUROLOGY

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer’s disease study cohorts from phase 3 trials of semagacestat and solanezumab

(2011) Christopher Carlson et al.   Alzheimers & Dementia

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Peripherally Applied A -Containing Inoculates Induce Cerebral  -Amyloidosis

(2010) Y. S. Eisele et al.   SCIENCE

Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease

(2009) K Kasuga et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY